Health6 hours ago
Moderna’s Cytomegalovirus Vaccine Trial Fails, Stock Drops 3.9%
Moderna has announced the failure of its late-stage trial for the mRNA-1647 vaccine, designed to prevent cytomegalovirus (CMV) infection. The trial, which primarily targeted seronegative women...